ArticleBMC molecular and cell biology2026
Insulin signaling engages divergent transcriptional mechanisms in neural and metabolic tissues.
Article in BMC molecular and cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInsulin signaling is a conserved regulator of growth, metabolism, and lifespan across metazoans. While its systemic roles are well established, the mechanisms by which insulin coordinates tissue-specific transcriptional programs that underlie distinct functional demands remain incompletely understood. In particular, the differential impact of reduced insulin signaling on different tissues has not been systematically explored.
resultsWe performed a comparative transcriptomic analysis of Drosophila melanogaster olfactory sensory neurons (OSNs) and fat body (Fb) to investigate how reduced insulin signaling remodels gene expression in neural and metabolic tissues. Across both tissue types, insulin reduction suppressed key pathways involved in protein synthesis and mRNA surveillance, indicating shared regulatory responses. However, distinct tissue-specific transcriptional adaptations were also observed. In OSNs, insulin reduction led to the upregulation of synaptic and signaling genes, alongside the downregulation of proteostasis-related factors, suggesting enhanced neural plasticity that may come at the cost of long-term neuronal maintenance. In contrast, the Fb exhibited widespread metabolic suppression accompanied by feedback activation of stress-responsive insulin-like peptide genes, consistent with a shift toward hypometabolic adaptation. Network and pathway analyses revealed that these tissue-specific responses involved distinct regulatory architectures affecting core insulin pathway components and gene families.
conclusionsOur findings demonstrate that reduced insulin signaling elicits both shared and divergent transcriptional programs in neural and metabolic tissues of Drosophila melanogaster. These findings reveal how insulin signaling orchestrates tissue-specific transcriptional landscapes that may underlie differential resilience or vulnerability to cognitive and metabolic decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.